- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
SonoSite revenues drop in 3Q
Revenues dropped 13% to $53.6 million for SonoSite in the third quarter compared with the year earlier period.
SonoSite revenues drop in 3Q
Revenues dropped 13% to $53.6 million for SonoSite in the third quarter compared with the year earlier period. The most recent quarter showed a deteriorating marketplace for the pioneer of hand-carried ultrasound as nine month revenues were down 9% compared with the first nine months of 2008. Foreign exchange had zero effect on third quarter revenue, according to the company, but a negative impact of $6.7 million or 4% for the nine months just ended. For the third quarter of 2009, the company recorded a net loss of $0.2 million compared with a net income of $3.7 million in 2008. For the nine months of 2009, net income was $1.0 million compared with $5.3 million. Kevin M. Goodwin, SonoSite president and CEO, said U.S. revenue levels continued to stabilize and the company ran into “a few” order delays in its international business. Importantly, he said, pricing and expense management have improved, resulting in steadily increasing operating margin performance.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
